Hangzhou Minsheng Healthcare Co., Ltd. (SHE:301507)
China · Delayed Price · Currency is CNY 12.66
-0.22 (-1.71%)
At close: Aug 24, 2026
SHE:301507 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 4,487 | 5,477 | 4,525 | 5,883 | - | - | |
Market Cap Growth | -17.42% | 21.04% | -23.09% | - | - | - |
Enterprise Value | 3,742 | 4,611 | 3,652 | 4,951 | - | - |
Last Close Price | 12.66 | 15.17 | 12.44 | 16.04 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 38.33 | 46.10 | 49.27 | 68.70 | - | - |
PS Ratio | 5.42 | 7.01 | 7.06 | 10.11 | - | - |
PB Ratio | 2.54 | 3.19 | 2.96 | 3.99 | - | - |
P/TBV Ratio | 3.01 | 3.79 | 3.03 | 4.11 | - | - |
P/FCF Ratio | - | - | 333.38 | 81.62 | - | - |
P/OCF Ratio | 26.13 | 30.91 | 41.72 | 54.40 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.52 | 5.90 | 5.70 | 8.51 | - | - |
EV/EBITDA Ratio | 30.31 | 40.41 | 37.46 | 46.86 | - | - |
EV/EBIT Ratio | 39.66 | 52.92 | 48.63 | 62.66 | - | - |
EV/FCF Ratio | - | - | 269.06 | 68.69 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.03 | 0.02 | 0.01 | 0.02 | 0.03 | 0.04 |
Debt / FCF Ratio | - | - | 0.08 | 0.03 | 0.05 | 0.19 |
Net Debt / Equity Ratio | -0.49 | -0.59 | -0.67 | -0.67 | -0.21 | -0.49 |
Net Debt / EBITDA Ratio | -7.07 | -8.89 | -10.60 | -9.30 | -1.15 | -2.76 |
Net Debt / FCF Ratio | 2371.53 | 52.94 | -76.10 | -13.64 | -1.79 | -13.44 |
Asset Turnover | 0.41 | 0.42 | 0.38 | 0.48 | 0.76 | 0.72 |
Inventory Turnover | 6.03 | 3.67 | 2.73 | 2.11 | 2.04 | 1.85 |
Quick Ratio | 3.22 | 3.99 | 5.37 | 6.26 | 0.92 | 1.83 |
Current Ratio | 3.83 | 4.62 | 6.09 | 7.08 | 1.88 | 2.74 |
Return on Equity (ROE) | 6.97% | 7.45% | 6.11% | 8.29% | 14.25% | 14.60% |
Return on Assets (ROA) | 2.90% | 2.90% | 2.77% | 4.09% | 6.51% | 5.68% |
Return on Invested Capital (ROIC) | 10.19% | 12.76% | 13.14% | 14.54% | 18.41% | 19.18% |
Return on Capital Employed (ROCE) | 5.20% | 5.00% | 4.90% | 5.30% | 12.40% | 11.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.65% | 2.17% | 2.03% | 1.46% | - | - |
FCF Yield | -0.01% | -0.35% | 0.30% | 1.23% | - | - |
Dividend Yield | 1.14% | 0.99% | 0.80% | 0.62% | - | - |
Payout Ratio | 29.91% | 29.92% | 38.83% | - | - | 214.14% |
Buyback Yield / Dilution | -1.91% | -1.92% | -19.61% | -12.12% | -1.26% | -9.28% |
Total Shareholder Return | -0.77% | -0.93% | -18.81% | -11.50% | -1.26% | -9.28% |